Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02334722 · ClinicalTrials.gov registry record · Phase 4
1 Week Versus 6 Weeks of Levetiracetam in Surgical Brain Tumor Patients
A Phase 4 study, sponsored by University of Florida.
- Completed
- Registry status
- Phase 4
- Development phase
- 81
- Enrollment target
NCT02334722 is a Phase 4 study that has completed, run by University of Florida. The registered enrollment target is 81 participants.
The verdict
NCT02334722, a Phase 4 study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 81 participants
- Enrollment target
Study Summary
The purpose of this study is to see if there are any differences in patient reported neurotoxicity between patients who receive Levetiracetam tablets for one week after surgery to remove a brain tumor versus those who receive Levetiracetam tablets for six weeks after surgery. Specifically, we will see if one group has less side effects than the other, and whether or not one group has more seizures than the other.
Interventions
- DRUG Levetiracetam
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 81 participants |
| Start Date | 2015-08-05 |
| Est. Completion | 2020-10-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02334722
The ClinicalTrials.gov registry entry for NCT02334722 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 81 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Levetiracetam is the first listed.
NCT02334722 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02334722 about?
NCT02334722 is a clinical study titled "1 Week Versus 6 Weeks of Levetiracetam in Surgical Brain Tumor Patients". The purpose of this study is to see if there are any differences in patient reported neurotoxicity between patients who receive Levetiracetam tablets for one week after surgery to remove a brain tumor versus those who receive Levetiracetam tablets for six weeks after surgery. Specifically, we will s...
What is the current status of trial NCT02334722?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 81 participants. The study started on 2015-08-05. Estimated completion is 2020-10-07.
What interventions are being tested in trial NCT02334722?
The interventions under investigation include: Levetiracetam (DRUG).
Who is sponsoring clinical trial NCT02334722?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.